Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03761394 · ClinicalTrials.gov registry record · NA
Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT03761394 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 120 participants.
The verdict
NCT03761394, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The goal of this research study is to develop a smartphone application capable of monitoring paroxysmal atrial fibrillation (pAF) in people who have survived a stroke or transient ischemic attack (TIA) or people who are at risk for a stroke and are age 50 and older. The study team plans to develop a highly effective and easy to use cardiovascular surveillance system to monitor patients for pAF on a nearly continuous basis. People involved in the development of this system include patients, their caregivers, health care providers, and computer programmers.
Interventions
- DEVICE Testing Devices
- DEVICE Cardea Solo by Cardiac Insight
- DEVICE Kardia Mobile by AliveCor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2019-09-03 |
| Est. Completion | 2021-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03761394
The ClinicalTrials.gov registry entry for NCT03761394 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Testing Devices is the first listed.
NCT03761394 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03761394 about?
NCT03761394 is a clinical study titled "Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke". The goal of this research study is to develop a smartphone application capable of monitoring paroxysmal atrial fibrillation (pAF) in people who have survived a stroke or transient ischemic attack (TIA) or people who are at risk for a stroke and are age 50 and older. The study team plans to develop a...
What is the current status of trial NCT03761394?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2019-09-03. Estimated completion is 2021-09-20.
What interventions are being tested in trial NCT03761394?
The interventions under investigation include: Testing Devices (DEVICE), Cardea Solo by Cardiac Insight (DEVICE), Kardia Mobile by AliveCor (DEVICE).
Who is sponsoring clinical trial NCT03761394?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.